APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

High-Purity PLGA Polymers for Long-Acting Injectables

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Growth and Trends Forecast to 2032

13 August 2026107 pages

Choose your research edition.

Industry ResearchHigh-Purity PLGA Polymers for Long-Acting Injectables Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal High-Purity PLGA Polymers for Long-Acting Injectables Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global High-Purity PLGA Polymers for Long-Acting Injectables market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for High-Purity PLGA Polymers for Long-Acting Injectables is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for High-Purity PLGA Polymers for Long-Acting Injectables is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High-Purity PLGA Polymers for Long-Acting Injectables is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of High-Purity PLGA Polymers for Long-Acting Injectables include Evonik Industries AG, Corbion N.V., Ashland Inc., SEQENS, Mitsui Chemicals, Inc., Nanjing Well Pharmaceutical Group Co., Ltd., Guangzhou DiQi Pharmaceuticals Co., Ltd., Nomisma Healthcare Pvt. Ltd. and Zhejiang Langhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global High-Purity PLGA Polymers for Long-Acting Injectables market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The High-Purity PLGA Polymers for Long-Acting Injectables market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global High-Purity PLGA Polymers for Long-Acting Injectables market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to High-Purity PLGA Polymers for Long-Acting Injectables.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global High-Purity PLGA Polymers for Long-Acting Injectables market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

High-Purity PLGA Polymers for Long-Acting Injectables Market by Company

Evonik Industries AG

Corbion N.V.

Ashland Inc.

SEQENS

Mitsui Chemicals, Inc.

Nanjing Well Pharmaceutical Group Co., Ltd.

Guangzhou DiQi Pharmaceuticals Co., Ltd.

Nomisma Healthcare Pvt. Ltd.

Zhejiang Langhua Pharmaceutical Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd.

Shanghai Libaimei Biotechnology Co., Ltd.

Zhejiang Bangyao Biomaterials Co., Ltd.

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Type

PLGA 50:50

PLGA 75:25

PLGA 85:15

Other Ratios and Customized PLGA

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Application

Sustained-release Microspheres

In-situ Forming Depot Systems

Biodegradable Drug-eluting Implants

Nanoparticle Drug Delivery Systems

Other Parenteral Controlled-release Applications

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Purity PLGA Polymers for Long-Acting Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High-Purity PLGA Polymers for Long-Acting Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Purity PLGA Polymers for Long-Acting Injectables.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of High-Purity PLGA Polymers for Long-Acting Injectables manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of High-Purity PLGA Polymers for Long-Acting Injectables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PLGA 50:50 Table 2. Major Company of PLGA 75:25 Table 3. Major Company of PLGA 85:15 Table 4. Major Company of Other Ratios and Customized PLGA Table 5. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 7. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type (2021-2026) Table 8. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 9. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type (2021-2026) Table 10. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2026) & (USD/t) Table 11. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 12. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type (2027-2032) Table 13. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (US$ Million) Table 14. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type (2027-2032) Table 15. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2027-2032) & (USD/t) Table 16. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 17. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 18. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 19. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 21. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 23. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 25. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (US$ Million) Table 26. High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends Table 27. High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers Table 28. High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges Table 29. High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints Table 30. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Company (2021-2026) Table 32. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Company (2021-2026) & (t) Table 33. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Company (2021-2026) Table 34. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Price by Company (2021-2026) & (USD/t) Table 35. Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global High-Purity PLGA Polymers for Long-Acting Injectables Major Company Production Sites and Headquarters Table 37. Global High-Purity PLGA Polymers for Long-Acting Injectables Company, Product Type & Application Table 38. Global High-Purity PLGA Polymers for Long-Acting Injectables Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global High-Purity PLGA Polymers for Long-Acting Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2021-2026) & (t) Table 43. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Region (2021-2026) Table 44. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2021-2026) & (US$ Million) Table 45. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Region (2021-2026) Table 46. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 47. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2027-2032) & (t) Table 48. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Region (2027-2032) Table 49. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2027-2032) & (US$ Million) Table 50. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Region (2027-2032) Table 51. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 52. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 54. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application (2021-2026) Table 55. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 56. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application (2021-2026) Table 57. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2026) & (USD/t) Table 58. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 59. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application (2027-2032) Table 60. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (US$ Million) Table 61. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application (2027-2032) Table 62. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2027-2032) & (USD/t) Table 63. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 64. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 65. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 66. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 68. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 70. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 72. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (US$ Million) Table 73. Evonik Industries AG Company Information Table 74. Evonik Industries AG Business Overview Table 75. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 77. Evonik Industries AG Recent Development Table 78. Corbion N.V. Company Information Table 79. Corbion N.V. Business Overview Table 80. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 82. Corbion N.V. Recent Development Table 83. Ashland Inc. Company Information Table 84. Ashland Inc. Business Overview Table 85. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 87. Ashland Inc. Recent Development Table 88. SEQENS Company Information Table 89. SEQENS Business Overview Table 90. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 92. SEQENS Recent Development Table 93. Mitsui Chemicals, Inc. Company Information Table 94. Mitsui Chemicals, Inc. Business Overview Table 95. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 97. Mitsui Chemicals, Inc. Recent Development Table 98. Nanjing Well Pharmaceutical Group Co., Ltd. Company Information Table 99. Nanjing Well Pharmaceutical Group Co., Ltd. Business Overview Table 100. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 102. Nanjing Well Pharmaceutical Group Co., Ltd. Recent Development Table 103. Guangzhou DiQi Pharmaceuticals Co., Ltd. Company Information Table 104. Guangzhou DiQi Pharmaceuticals Co., Ltd. Business Overview Table 105. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 107. Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Development Table 108. Nomisma Healthcare Pvt. Ltd. Company Information Table 109. Nomisma Healthcare Pvt. Ltd. Business Overview Table 110. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 112. Nomisma Healthcare Pvt. Ltd. Recent Development Table 113. Zhejiang Langhua Pharmaceutical Co., Ltd. Company Information Table 114. Zhejiang Langhua Pharmaceutical Co., Ltd. Business Overview Table 115. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 117. Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Development Table 118. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 119. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 120. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 122. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 123. Shanghai Libaimei Biotechnology Co., Ltd. Company Information Table 124. Shanghai Libaimei Biotechnology Co., Ltd. Business Overview Table 125. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 126. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 127. Shanghai Libaimei Biotechnology Co., Ltd. Recent Development Table 128. Zhejiang Bangyao Biomaterials Co., Ltd. Company Information Table 129. Zhejiang Bangyao Biomaterials Co., Ltd. Business Overview Table 130. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 131. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 132. Zhejiang Bangyao Biomaterials Co., Ltd. Recent Development Table 133. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 134. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 135. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Country (2021-2026) Table 136. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032) & (t) Table 137. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share Forecast by Country (2027-2032) Table 138. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026) & (US$ Million) Table 140. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country (2021-2026) Table 141. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Share Forecast by Country (2027-2032) Table 143. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 144. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 145. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Country (2021-2026) Table 146. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032) & (t) Table 147. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share Forecast by Country (2027-2032) Table 148. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country (2021-2026) Table 151. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 155. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032) & (t) Table 157. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country (2021-2026) Table 161. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Share Forecast by Country (2027-2032) Table 163. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 164. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 165. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Country (2021-2026) Table 166. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032) & (t) Table 167. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country (2021-2026) Table 171. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 175. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032) & (t) Table 177. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country (2021-2026) Table 181. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. High-Purity PLGA Polymers for Long-Acting Injectables Distributors List Table 186. High-Purity PLGA Polymers for Long-Acting Injectables Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. High-Purity PLGA Polymers for Long-Acting Injectables Image Figure 2. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size (2021-2032) & (US$ Million) Figure 4. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (2021-2032) & (t) Figure 5. PLGA 50:50 Image Figure 6. Global PLGA 50:50 Sales YoY Growth (2021-2032) & (t) Figure 7. PLGA 75:25 Image Figure 8. Global PLGA 75:25 Sales YoY Growth (2021-2032) & (t) Figure 9. PLGA 85:15 Image Figure 10. Global PLGA 85:15 Sales YoY Growth (2021-2032) & (t) Figure 11. Other Ratios and Customized PLGA Image Figure 12. Global Other Ratios and Customized PLGA Sales YoY Growth (2021-2032) & (t) Figure 13. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Type 2025 VS 2032 Figure 15. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type in 2025 Figure 16. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type in 2025 Figure 17. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type in 2025 Figure 18. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type in 2025 Figure 21. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type in 2025 Figure 22. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 High-Purity PLGA Polymers for Long-Acting Injectables Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Sustained-release Microspheres Image Figure 28. Global Sustained-release Microspheres Sales YoY Growth (2021-2032) & (t) Figure 29. In-situ Forming Depot Systems Image Figure 30. Global In-situ Forming Depot Systems Sales YoY Growth (2021-2032) & (t) Figure 31. Biodegradable Drug-eluting Implants Image Figure 32. Global Biodegradable Drug-eluting Implants Sales YoY Growth (2021-2032) & (t) Figure 33. Nanoparticle Drug Delivery Systems Image Figure 34. Global Nanoparticle Drug Delivery Systems Sales YoY Growth (2021-2032) & (t) Figure 35. Other Parenteral Controlled-release Applications Image Figure 36. Global Other Parenteral Controlled-release Applications Sales YoY Growth (2021-2032) & (t) Figure 37. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Application 2025 VS 2032 Figure 39. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application in 2025 Figure 40. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application in 2025 Figure 41. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application in 2025 Figure 42. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application in 2025 Figure 45. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application in 2025 Figure 46. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share in Value by Application in 2025 Figure 49. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 66. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. High-Purity PLGA Polymers for Long-Acting Injectables Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. High-Purity PLGA Polymers for Long-Acting Injectables Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • PLGA 50:50
  • PLGA 75:25
  • PLGA 85:15
  • Other Ratios and Customized PLGA
Applications
  • Sustained-release Microspheres
  • In-situ Forming Depot Systems
  • Biodegradable Drug-eluting Implants
  • Nanoparticle Drug Delivery Systems
  • Other Parenteral Controlled-release Applications
Companies covered
  • Evonik Industries AG
  • Corbion N.V.
  • Ashland Inc.
  • SEQENS
  • Mitsui Chemicals, Inc.
  • Nanjing Well Pharmaceutical Group Co., Ltd.
  • Guangzhou DiQi Pharmaceuticals Co., Ltd.
  • Nomisma Healthcare Pvt. Ltd.
  • Zhejiang Langhua Pharmaceutical Co., Ltd.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Shanghai Libaimei Biotechnology Co., Ltd.
  • Zhejiang Bangyao Biomaterials Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Estimates and Forecasts (2021-2032)
  5. 1.3 High-Purity PLGA Polymers for Long-Acting Injectables Market by Type
  6. 1.3.1 PLGA 50:50
  7. 1.3.2 PLGA 75:25
  8. 1.3.3 PLGA 85:15
  9. 1.3.4 Other Ratios and Customized PLGA
  10. 1.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  11. 1.4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends
  2. 2.2 High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers
  3. 2.3 High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges
  4. 2.4 High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2026)
  2. 3.2 Global Top Players by High-Purity PLGA Polymers for Long-Acting Injectables Sales (2021-2026)
  3. 3.3 Global Top Players by High-Purity PLGA Polymers for Long-Acting Injectables Price (2021-2026)
  4. 3.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global High-Purity PLGA Polymers for Long-Acting Injectables Major Company Production Sites & Headquarters
  6. 3.6 Global High-Purity PLGA Polymers for Long-Acting Injectables Company, Product Type & Application
  7. 3.7 Global High-Purity PLGA Polymers for Long-Acting Injectables Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 High-Purity PLGA Polymers for Long-Acting Injectables Players Market Share by Revenue in 2025
  11. 3.8.3 2025 High-Purity PLGA Polymers for Long-Acting Injectables Tier 1, Tier 2, and Tier 3
4 High-Purity PLGA Polymers for Long-Acting Injectables Regional Status and Outlook
  1. 4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Historic Market Size by Region
  3. 4.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales in Value by Region (2021-2026)
  5. 4.2.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Market Size by Region
  7. 4.3.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales in Value by Region (2027-2032)
  9. 4.3.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 High-Purity PLGA Polymers for Long-Acting Injectables by Application
  1. 5.1 High-Purity PLGA Polymers for Long-Acting Injectables Market by Application
  2. 5.1.1 Sustained-release Microspheres
  3. 5.1.2 In-situ Forming Depot Systems
  4. 5.1.3 Biodegradable Drug-eluting Implants
  5. 5.1.4 Nanoparticle Drug Delivery Systems
  6. 5.1.5 Other Parenteral Controlled-release Applications
  7. 5.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  8. 5.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Evonik Industries AG
  2. 6.1.1 Evonik Industries AG Company Information
  3. 6.1.2 Evonik Industries AG Business Overview
  4. 6.1.3 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  6. 6.1.5 Evonik Industries AG Recent Developments
  7. 6.2 Corbion N.V.
  8. 6.2.1 Corbion N.V. Company Information
  9. 6.2.2 Corbion N.V. Business Overview
  10. 6.2.3 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  12. 6.2.5 Corbion N.V. Recent Developments
  13. 6.3 Ashland Inc.
  14. 6.3.1 Ashland Inc. Company Information
  15. 6.3.2 Ashland Inc. Business Overview
  16. 6.3.3 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  18. 6.3.5 Ashland Inc. Recent Developments
  19. 6.4 SEQENS
  20. 6.4.1 SEQENS Company Information
  21. 6.4.2 SEQENS Business Overview
  22. 6.4.3 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  24. 6.4.5 SEQENS Recent Developments
  25. 6.5 Mitsui Chemicals, Inc.
  26. 6.5.1 Mitsui Chemicals, Inc. Company Information
  27. 6.5.2 Mitsui Chemicals, Inc. Business Overview
  28. 6.5.3 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  30. 6.5.5 Mitsui Chemicals, Inc. Recent Developments
  31. 6.6 Nanjing Well Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Nanjing Well Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Nanjing Well Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  36. 6.6.5 Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Guangzhou DiQi Pharmaceuticals Co., Ltd.
  38. 6.7.1 Guangzhou DiQi Pharmaceuticals Co., Ltd. Company Information
  39. 6.7.2 Guangzhou DiQi Pharmaceuticals Co., Ltd. Business Overview
  40. 6.7.3 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  42. 6.7.5 Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments
  43. 6.8 Nomisma Healthcare Pvt. Ltd.
  44. 6.8.1 Nomisma Healthcare Pvt. Ltd. Company Information
  45. 6.8.2 Nomisma Healthcare Pvt. Ltd. Business Overview
  46. 6.8.3 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  48. 6.8.5 Nomisma Healthcare Pvt. Ltd. Recent Developments
  49. 6.9 Zhejiang Langhua Pharmaceutical Co., Ltd.
  50. 6.9.1 Zhejiang Langhua Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Zhejiang Langhua Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  54. 6.9.5 Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Hunan Er-Kang Pharmaceutical Co., Ltd.
  56. 6.10.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  60. 6.10.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Shanghai Libaimei Biotechnology Co., Ltd.
  62. 6.11.1 Shanghai Libaimei Biotechnology Co., Ltd. Company Information
  63. 6.11.2 Shanghai Libaimei Biotechnology Co., Ltd. Business Overview
  64. 6.11.3 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  66. 6.11.5 Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments
  67. 6.12 Zhejiang Bangyao Biomaterials Co., Ltd.
  68. 6.12.1 Zhejiang Bangyao Biomaterials Co., Ltd. Company Information
  69. 6.12.2 Zhejiang Bangyao Biomaterials Co., Ltd. Business Overview
  70. 6.12.3 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  72. 6.12.5 Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country
  2. 7.1.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026)
  4. 7.1.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032)
  5. 7.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  6. 7.2.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026)
  8. 7.2.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country
  2. 8.1.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026)
  4. 8.1.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032)
  5. 8.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  6. 8.2.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026)
  8. 8.2.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country
  2. 9.1.1 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  6. 9.2.1 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country
  2. 10.1.1 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026)
  4. 10.1.3 South America High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032)
  5. 10.2 South America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  6. 10.2.1 South America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026)
  8. 10.2.3 South America High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country
  2. 11.1.1 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  6. 11.2.1 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 High-Purity PLGA Polymers for Long-Acting Injectables Value Chain Analysis
  2. 12.1.1 High-Purity PLGA Polymers for Long-Acting Injectables Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 High-Purity PLGA Polymers for Long-Acting Injectables Production Mode & Process
  7. 12.2 High-Purity PLGA Polymers for Long-Acting Injectables Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 High-Purity PLGA Polymers for Long-Acting Injectables Distributors
  10. 12.2.3 High-Purity PLGA Polymers for Long-Acting Injectables Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst